Skip to main content
Premium Trial:

Request an Annual Quote

BSI Proteomics to Determine Structure of CF Membrane Protein

NEW YORK, March 21 (GenomeWeb News) - BSI Proteomics said last week that it will perform protein crystallization and structure determination services for the Cystic Fibrosis Foundation.


The foundation selected BSI to express, purify, crystallize, and determine the structure of the cystic fibrosis trans-conductance protein, a membrane protein that has proved difficult to purify, according to the Gaithersburg, MD.-based firm.


BSI will use its Membrane Protein Stabilization System, which has particular capabilities for stabilizing membrane, ion-channel, and other "difficult" soluble proteins, the company said. BSI claims that its technology can produce diffractable crystals in months, compared to years required for other methods.


The company did not disclose any financial terms for its agreement with the Cystic Fibrosis Foundation.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.